Lv72
4128 积分 2022-09-22 加入
New Criteria for Histologic Grading of Colorectal Cancer
29天前
已完结
Histological Grading of Colorectal Cancer
29天前
已完结
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis
1个月前
已完结
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
3个月前
已完结
Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
3个月前
已完结
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
3个月前
已完结
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
4个月前
已完结
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis
5个月前
已完结
Diagnosis and Treatment of AL Amyloidosis
5个月前
已完结
皖公网安备34019202002308
